Search Result "anti-PD1"
Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21 Issue: 10 Year: 2018 Page: 711-717
Author(s): Chu-Hui Ru,Yan-Bing Zhuang
Immunotherapy-Associated Hypophysitis under Anti-PD1: Two CaseReports
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 7 Year: 2023 Page: 996-1004
Author(s):
New Treatments for Cutaneous Metastatic Melanoma: MAPK Pathway-Targeted and Immune Based Therapies
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 4 Year: 2015 Page: 461-467
Author(s): F. Ranchon,A. Boespflug,C. Rioufol,V. Schwiertz,L. Thomas,S. Dalle
Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10 Issue: 2 Year: 2015 Page: 133-144
Author(s): Teresa C. Longoria,Ramez N. Eskander
Immunotherapy of Melanoma
Journal: Current Molecular Pharmacology
Volume: 9 Issue: 3 Year: 2016 Page: 196-207
Author(s): Ahmad A. Tarhini
Potential Indications of Dupilumab in Th-2 Inflammatory Disease
Journal: Reviews on Recent Clinical Trials
Volume: 19 Issue: 1 Year: 2024 Page: 53-61
Author(s):
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2019 Page: 290-303
Author(s): Izabela ÅasiÅska,Tomasz Kolenda,Anna Teresiak,Katarzyna M. Lamperska,Åukasz Galus,Jacek Mackiewicz
Cancer Stem Cells and Anti-tumor Immunity
Journal: Current Stem Cell Research & Therapy
Volume: 18 Issue: 4 Year: 2023 Page: 445-459
Author(s): Sergei M. Gryaznov,Z. Gunnur Dikmen
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
Journal: Current Drug Safety
Volume: 13 Issue: 3 Year: 2018 Page: 150-164
Author(s): Devis Benfaremo,Lucia Manfredi,Michele Maria Luchetti,Armando Gabrielli
Occurrence and Severity of Adverse Reactions of Immune CheckpointInhibitors (PD-1 and PD L1) Based on Mordovian Dispensary DataAnalysis
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 51-56
Author(s): Basheer Marzoog